StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.48−0.08 (-5.13%)

Close on Nov 17, 2026Market cap $526.23MP/E –Yield –

Evotec pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Evotec's pe ratio was 12.9× on Feb 28, 2023, against 653.5× a year earlier. Over the last 3 years it ranged from 11.6× to 962.8×, with a median of 91.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 202312.9×+1.3
2022Dec 30, 202211.6×−847.8
2021Jul 30, 2021859.4×+739.4
2020Dec 31, 2020120.0×–

More Evotec figures

See a number that looks wrong?